Sign In
Buy GTHP
$0.228
+0 (+0%)
At Close: Jun 03, 2026
Haemonetics (NYSE:HAE) vs. Guided Therapeutics (OTCMKTS:GTHP) Head to Head Review
01:13am, Friday, 03'rd Apr 2026
Haemonetics (NYSE: HAE - Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses ba
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
09:00am, Tuesday, 31'st Mar 2026
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba
Guided Therapeutics (OTCMKTS:GTHP) Shares Down 12.7% – Time to Sell?
02:13am, Tuesday, 10'th Mar 2026
Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price fell 12.7% on Monday. The company traded as low as $0.2620 and last traded at $0.2620. 3,800 shares traded hands during mid-day
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
09:00am, Wednesday, 17'th Dec 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
09:00am, Wednesday, 19'th Nov 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo M
Guided Therapeutics (OTCMKTS:GTHP) Trading 25.6% Higher – Here’s What Happened
02:30am, Tuesday, 18'th Nov 2025
Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price was up 25.6% during trading on Monday. The stock traded as high as $0.25 and last traded at $0.2010. Approximately 3,114 shares
Guided Therapeutics (OTCMKTS:GTHP) Trading Down 7.9% – Here’s What Happened
02:52am, Friday, 24'th Oct 2025
Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report) shares traded down 7.9% during trading on Thursday. The stock traded as low as $0.23 and last traded at $0.23. 2,206 shares were traded during
Contrasting Surmodics (NASDAQ:SRDX) and Guided Therapeutics (OTCMKTS:GTHP)
01:14am, Monday, 20'th Oct 2025
Surmodics (NASDAQ: SRDX - Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two compan
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
09:00am, Wednesday, 13'th Aug 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
09:00am, Wednesday, 02'nd Jul 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on June 27th that it made its first shipment of devices
Guided Therapeutics Receives $100,000 from SMI's Investment Partners to Continue Commercialization Process of LuViva in China
09:00am, Tuesday, 27'th May 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a $100,000 payment from Shandong
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
09:28am, Tuesday, 10'th Dec 2024
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received full payment from its Indonesian
Guided Therapeutics Schedules Conference Call to Discuss Third Quarter 2015 Financial Results
09:05am, Friday, 06'th Nov 2015
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will r
Guided Therapeutics Schedules Conference Call to Discuss Second Quarter 2015 Financial Results
02:02pm, Tuesday, 04'th Aug 2015
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will r
FDA Completes Review of Guided Therapeutics’ LuViva® Advanced Cervical Scan PMA Application
04:05pm, Tuesday, 19'th May 2015
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has received notification from the U.S. Food and Drug Administration (FDA) regarding the p
